Diarrhea News and Research

RSS
Diarrhea is loose, watery stools. A person with diarrhea typically passes stool more than three times a day. People with diarrhea may pass more than a quart of stool a day. Acute diarrhea is a common problem that usually lasts 1 or 2 days and goes away on its own without special treatment. Prolonged diarrhea persisting for more than 2 days may be a sign of a more serious problem and poses the risk of dehydration. Chronic diarrhea may be a feature of a chronic disease.

Diarrhea can cause dehydration, which means the body lacks enough fluid to function properly. Dehydration is particularly dangerous in children and older people, and it must be treated promptly to avoid serious health problems.
Symptoms, triggers of food intolerance found to be similar in animals and humans

Symptoms, triggers of food intolerance found to be similar in animals and humans

New analysis finds link between cloudy drinking water and gastrointestinal illness

New analysis finds link between cloudy drinking water and gastrointestinal illness

Study shows sustained impact and effectiveness of rotavirus vaccine program

Study shows sustained impact and effectiveness of rotavirus vaccine program

Colorectal cancer deaths on the rise among Americans: JAMA study

Colorectal cancer deaths on the rise among Americans: JAMA study

Increase in reported cases of Cyclospora infections compared to last year, CDC reports

Increase in reported cases of Cyclospora infections compared to last year, CDC reports

Scientists take steps to inhibit impact of E. coli on human health

Scientists take steps to inhibit impact of E. coli on human health

Protein-rich diet may foster more tolerant, less inflammatory gut environment

Protein-rich diet may foster more tolerant, less inflammatory gut environment

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Breastfeeding is currently failing to meet recommended standards across the globe, UNICEF and WHO report reveals

Breastfeeding is currently failing to meet recommended standards across the globe, UNICEF and WHO report reveals

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Two new discoveries provide better understanding of how bacteria resist antibiotics

Two new discoveries provide better understanding of how bacteria resist antibiotics

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Genetic test to predict IBD severity in children

Genetic test to predict IBD severity in children

Living in rural households lowers person's risk of developing IBD, study finds

Living in rural households lowers person's risk of developing IBD, study finds

Multistate Salmonella outbreak linked to Maradol Papaya: CDC reports

Multistate Salmonella outbreak linked to Maradol Papaya: CDC reports

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Global multi-stakeholder partnerships improve health of women, children, and adolescents

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence